Adhoc: Curatis Holding AG: Curatis and Neupharma announce exclusive licensing agreement to develop and market corticorelin (C-PTBE-01) for the treatment of peritumoral brain edema in Japan
Curatis Holding AG / Key word(s): Agreement/Partnership Curatis and Neupharma announce exclusive licensing agreement to develop and market corticorelin (C-PTBE-01) for the treatment of peritumoral… Weiterlesen auf der Quellseite
